共 8 条
- [1] Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803 [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) : 5182 - 5188
- [2] Chen B, 2007, CLIN OPHTHALMIC ONCO, P581
- [3] Huh WW, 2011, MD ANDERSON SOLID TU, P61, DOI 10.1007/978-1-4419-0374-7_4
- [4] DEVELOPMENTAL ORIGINS OF FUSION-NEGATIVE RHABDOMYOSARCOMAS [J]. CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY: MYOGENESIS, 2011, 96 : 33 - 56
- [7] PROGNOSTIC FACTORS IN 951 NONMETASTATIC RHABDOMYOSARCOMA IN CHILDREN - A REPORT FROM THE INTERNATIONAL RHABDOMYOSARCOMA WORKSHOP [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1991, 19 (02): : 89 - 95